Interest Paid, Excluding Capitalized Interest, Operating Activities of Regulus Therapeutics Inc. from 31 Dec 2016 to 31 Mar 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Regulus Therapeutics Inc. quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 31 Dec 2016 to 31 Mar 2025.
- Regulus Therapeutics Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Mar 2025 was $5,000, a 89% decline year-over-year.
- Regulus Therapeutics Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $66,000, a 85% decline from 2023.
- Regulus Therapeutics Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $447,000, a 9% decline from 2022.
- Regulus Therapeutics Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $491,000, a 33% decline from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)